Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
-31.4%/yr
Quarterly compound
Percentile
P53
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.80% |
| Q3 2025 | 8.28% |
| Q2 2025 | 4.18% |
| Q1 2025 | -4.80% |
| Q4 2024 | 3.99% |
| Q3 2024 | 0.10% |
| Q2 2024 | 6.46% |
| Q1 2024 | 6.84% |
| Q4 2023 | -0.49% |
| Q3 2023 | 3.50% |
| Q2 2023 | 7.44% |
| Q1 2023 | -8.56% |
| Q4 2022 | 11.77% |
| Q3 2022 | -2.47% |
| Q2 2022 | 12.40% |
| Q1 2022 | -7.31% |
| Q4 2021 | 1.57% |
| Q3 2021 | -1.21% |
| Q2 2021 | 8.51% |
| Q1 2021 | -3.32% |
| Q4 2020 | -1.78% |
| Q3 2020 | 11.76% |
| Q2 2020 | -6.79% |
| Q1 2020 | 25.47% |
| Q4 2019 | 5.03% |
| Q3 2019 | -6.51% |
| Q2 2019 | -9.30% |
| Q1 2019 | -10.33% |
| Q4 2018 | 4.42% |
| Q3 2018 | 15.15% |
| Q2 2018 | 50.36% |
| Q1 2018 | -6.20% |
| Q4 2017 | 15.17% |
| Q3 2017 | -1.98% |
| Q2 2017 | 15.15% |
| Q1 2017 | -24.41% |
| Q4 2016 | 0.00% |